Effect of domperidone on apomorphine-induced growth hormone secretion in normal men

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of neural transmission

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF01249280PMID 7108512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of sleep deprivation on dopamine receptor function in normal subjects

  2005cited by this paper
• Effect of choline on central dopaminergic function in normal subjects

  2005cited by this paper
• Neuroendocrine Evaluation of Catecholaminergic Function in Man

  1984cited by this paper
• Electroconvulsive therapy and receptor sensitivity

  1981cited by this paper
• Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.

  1981cited by this paper
• Doctors' wider responsibilities.

  1981cited by this paper
• Effect of gamma-aminobutyric acid on growth hormone and prolactin secretion in man: influence of pimozide and domperidone.

  1980cited by this paper
• [3H]Spiperone binding to human anterior pituitaries and pituitary adenomas secreting prolactin, growth hormone, and adrenocorticotropic hormone.

  1980cited by this paper
• Effects of prolonged dopamine infusion on anterior pituitary function in normal males.

  1980cited by this paper
• Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity.

  1979cited by this paper
• Neuroendocrine Effects of Apomorphine: Characterization of Response Patterns and Application to Schizophrenia Research

  1979cited by this paper
• A study of growth hormone release in depression.

  1979cited by this paper
• Sleep induced by low doses of apomorphine in rats.

  1979cited by this paper
• Apocodeine-induced stereotypies and penile erection in rats.

  1979cited by this paper
• Anterior pituitary adenylate cyclase: stimulation by dopamine and other monoamines.

  1979cited by this paper
• Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease.

  1979cited by this paper
• [3H]Spiroperidol (spiperone) binding to a putative dopamine receptor in sheep and steer pituitary and stalk median eminence.

  1979cited by this paper
• Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson's disease.

  1979cited by this paper
• Prolactin responses to neuroleptics in normal and schizophrenic subjects.

  1978cited by this paper
• Effect of lithium on hypothalamic‐pituitary dopaminergic function

  1978cited by this paper
• Effect of dopamine and neuroleptics on plasma growth hormone and prolactin in normal men.

  1978cited by this paper
• Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release.

  1978cited by this paper
• Dopamine and dihydroergocryptine binding to the anterior pituitary and other brain areas of the rat and sheep.

  1978cited by this paper
• Dopamine affects basal and augmented pituitary hormone secretion.

  1978cited by this paper
• Effect of monoamine receptor agonists and antagonists on cyclic AMP accumulation in human cerebral cortex slices.

  1977cited by this paper
• Effect of methysergide and pimozide on apomorphine-induced growth hormone secretion in men.

  1977cited by this paper
• Lithium inhibition of cyclic AMP accumulation induced by dopamine in isolated retinae of the rabbit.

  1977cited by this paper
• Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.

  1977cited by this paper
• Adenylate cyclase from various dopaminergic areas of the brain and the action of antipsychotic drugs.

  1977cited by this paper
• Postsynaptic supersensitivity in schizophrenia.

  1977cited by this paper
• Dr. Pandey and Associates Reply

  1977cited by this paper
• TRH and dopamine interactions affecting pituitary hormones secretion.

  1977cited by this paper
• Neurotransmitter-sensitive adenylate cyclase in the hypothalami of guinea-pig, rat and monkey.

  1977cited by this paper
• Dopamine/neuroleptic receptors in basal hypothalamus and pituitary.

  1976cited by this paper
• Effects of dopamine infusion on pituitary hormone secretion in humans.

  1976cited by this paper
• Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.

  1976cited by this paper
• Apomorphine and psychopathology.

  1975cited by this paper
• Apomorphine and Its Relation to Dopamine in the Nervous System

  1975cited by this paper
• Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol.

  1975cited by this paper
• Letter: Danfa project.

  1974cited by this paper
• Inhibition by apomorphine of prolactin secretion in patients with elevated serum prolactin.

  1974cited by this paper
• Potentiation of levodopa stimulation of human growth hormone by systemic decarboxylase inhibition

  1973cited by this paper
• A homologous radioimmunoassay for human prolactin.

  1973cited by this paper
• Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum.

  1973cited by this paper
• Treatment of alcoholism with Dent's oral apomorphine method.

  1972cited by this paper
• Effect of apomorphine on human-growth-hormone secretion.

  1972cited by this paper
• A radioimmunoassay for human prolactin.

  1971cited by this paper
• The biosynthesis of human growth hormone and prolactin.

  1970cited by this paper
• The permeability of the hypophysis and hypothalamus to vital dyes, with a study of the hypophyseal vascular supply

  1936cited by this paper

• Professional Profile

  2018cites this paper
• Impaired Sexual Function

  2013cites this paper
• Drug-Induced Yawning—A Review

  2011cites this paper
• Erectile dysfunction in Parkinson's disease.

  2006cites this paper
• Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers

  2006cites this paper
• Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man

  2005cites this paper
• Systemic administration of apomorphine improves the hemodynamic mechanism of clitoral and vaginal engorgement in the rabbit

  2000cites this paper
• Effect of Time-of-Day on the Yawning Response to Apomorphine in Normal Subjects

  2000cites this paper
• Apomorphine‐induced penile erections in Parkinson's disease

  1998cites this paper
• The effect of Yohimbine, an alpha2 adrenergic receptor antagonist, on the growth hormone response to apomorphine in normal subjects.

  1996cites this paper
• Dopamine Supersensitivity and Hormonal Status in Puerperal Psychosis

  1995cites this paper
• Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches.

  1994cites this paper
• The effect of methyltestosterone on the growth hormone response to the dopamine receptor agonist, apomorphine.

  1991cites this paper
• Quinelorane (LY163502), a D2 dopamine receptor agonist, acts centrally to facilitate penile erections of male rhesus monkeys.

  1991cites this paper
• Effect of apomorphine on penile tumescence in men with psychogenic impotence.

  1991cites this paper
• Apomorphine facilitates male sexual behavior of rhesus monkeys.

  1990cites this paper
• Effect of some peptides on dopaminergic function in man.

  1990cites this paper
• Effects of psychotropic drugs on human erection and ejaculation.

  1989cites this paper
• Apomorphine: clinical studies on erectile impotence and yawning.

  1989cites this paper
• Growth hormone response to apomorphine, a dopamine receptor agonist, in normal aging and in dementia of the Alzheimer type.

  1989cites this paper
• Effect of hydrocortisone on basal and apomorphine-induced growth hormone secretion in normal subjects.

  1988cites this paper
• Apomorphine in the evaluation of dopaminergic function in man.

  1988cites this paper
• Effect of apomorphine on melatonin secretion in normal subjects

  1987cites this paper
• A simple method for the study of yawning in man induced by the dopamine receptor agonist, apomorphine.

  1987cites this paper
• Cholecystokinin and schizophrenia.

  1986cites this paper
• CCK-8 Antagonizes Apomorphine-Induced Growth Hormone Secretion in Normal Subjects

  1986cites this paper
• Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects.

  1984cites this paper
• Apomorphine does not lower the concentration of homovanillic acid in the plasma of normal humans.

  1984cites this paper
• CCK-33 antagonizes apomorphine-induced growth hormone secretion and increases basal prolactin levels in man.

  1984cites this paper
• Effect of CCK-33 on Prolactin and Apomorphine-Induced Growth Hormone Secretion in Man

  1983cites this paper
• Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man.

  1983cites this paper
• Drug-induced growth hormone and prolactin responses in schizophrenia research.

  1982cites this paper